-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Thrombopoiesis Stimulating Agents: Are They Safe in Hematologic Malignancies?

Program: Spotlight Sessions
Session: Addressing Severe Thrombocytopenia in the Care of Patients with Myelodysplastic Syndromes and Other Hematological Malignancies
Monday, December 7, 2015, 2:45 PM-4:15 PM
W312, Level 3 (Orange County Convention Center)

Aristoteles Giagounidis, MD

Klinik für Onkologie, Hämatologie und Palliativmedizin, Marienhospital Düsseldorf, Düsseldorf, Germany

Disclosures: No relevant conflicts of interest to declare.

See more of: Addressing Severe Thrombocytopenia in the Care of Patients with Myelodysplastic Syndromes and Other Hematological Malignancies
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation